Treatment Failures in the Idiopathic Intracranial Hypertension Treatment Trial (Video)

Update item information
Identifier 20150225_nanos_hottopic2_03
Title Treatment Failures in the Idiopathic Intracranial Hypertension Treatment Trial (Video)
Creator Julie Falardeau, MD Oregon Health Science University, Casey Eye Institute, Portland, OR
Subject Intracranial hypertension, Vision loss, Treatment failure, Transient visual obscuration, Papilledema
Description The purpose of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) was to determine whether acetazolamide is beneficial in improving vision when added to a low sodium, weight reduction diet in idiopathic intracranial hypertension (IIH) patients with mild visual loss. During the first six months of the intervention phase, six subjects on placebo and one subject on acetazolamide met criteria for treatment failure. Male patients, those with high grade papilledema and those with decreased visual acuity at baseline were more likely to experience treatment failure.
Relation is Part of NANOS Annual Meeting 2015 Sizzling Hot Topic: The IIHTT: What Have We Learned?
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2015-02-25
Type Text
Format video/mp4
Format Creation application/video
Source 2015 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2017. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL
Language eng
ARK ark:/87278/s6p59bm2
Setname ehsl_novel_nam
Date Created 2017-04-27
Date Modified 2017-05-01
ID 1248270
Reference URL